JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Prevalence of Trichomonas vaginalis infection in symptomatic adolescent females presenting to a pediatric emergency department.

OBJECTIVES: Adolescent females are disproportionately affected by sexually transmitted infections (STIs). Although Trichomonas vaginalis (TV) has been declared the most common nonviral STI, TV testing is not routinely conducted in the emergency department (ED), and when it is performed, insensitive testing methods are often used. Therefore, this study sought to determine the prevalence of TV and factors associated with TV infection among symptomatic adolescent females presenting to a pediatric ED.

METHODS: This was a prospective prevalence study of female patients ages 14 to 19 years presenting to a pediatric ED with lower abdominal pain and/or genitourinary (GU) complaints. Patients were tested for TV, Neisseria gonorrhoeae (GC), and Chlamydia trachomatis (CT).

RESULTS: Of the 276 patients who met inclusion criteria, 203 underwent TV testing; prevalence was 9.9% (95% confidence interval [CI] = 5.7% to 14.0%). Assuming all eligible patients who did not have TV testing were not infected with TV, sensitivity analysis revealed a minimum TV prevalence of 7.2% (95% CI = 4.2% to 10.3%). The overall prevalence of any STI was 22.5% (95% CI = 17.5% to 27.4%), with CT being the most prevalent (19.7%; 95% CI = 14.5 to 24.9). Aside from vaginal discharge (odds ratio [OR] = 3.7; 95% CI = 1.1 to 11.3), there were no other factors significantly associated with TV infection.

CONCLUSIONS: A substantial proportion of adolescent females presenting to a pediatric ED with lower abdominal or GU symptoms had TV infection. TV testing should be considered as part of the evaluation of adolescent females presenting to the ED with lower abdominal, urinary, or vaginal complaints.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app